Gavi 6.0 funding guidelines
Newly released funding guidelines outline the scope of Gavi’s vaccine and cash support for the 2026–2030 strategic period (Gavi 6.0), explain how countries should plan and prioritise their immunisation programmes within this support, clarify the requirements for the Gavi 6.0 country application and describe how to access other forms of assistance such as outbreak and emergency support.
Leaving no one behind with immunisation
Gavi, the Vaccine Alliance is a public-private partnership that helps vaccinate more than half the world’s children against some of the world's deadliest diseases.
About us Explore our Progress Report
Latest VaccinesWork features
View moreWhy forest conservation is also public health
New research illustrates how improved ecological monitoring can connect conservation and public health, supporting the view that protecting ecosystems and managing disease risk are closely linked.
In Madagascar, stigma is undermining the fight against mpox
Vaccines are now rolling out to protect the people at highest risk, shielding them from both the virus and social ostracism.
Could some common antibiotics be inflaming bacterial infections?
The antibiotics most often used to treat sepsis may trigger bacteria to release more inflammation-driving particles than other antibiotic classes, a new study shows.

VaccinesWork is an award-winning digital platform hosted by Gavi, covering news, features and explainers from every corner of global health and immunisation.
Our work

Vaccine portfolio
Gavi supports vaccines against 20 infectious diseases, including Ebola, malaria, mpox and rabies.

Health systems support
Strong health and immunisation systems are vital to deliver vaccines to all the children who need them.

Civil society support
We provide grants for civil society organisations (CSOs) working to reach zero-dose children and missed communities with vaccines.
Latest Gavi news releases
View allThe Government of Burundi introduces the HPV vaccine to protect girls and prevent cervical cancer
Under the leadership of the Ministry of Public Health and with the support of Gavi, UNICEF, and the WHO, Burundi has just launched, on April 29, 2026, the vaccine against HPV, which causes cervical cancer.
Marking World Immunization Week 2026, the International Rescue Committee (IRC) announced that, together with partners in the Gavi-funded REACH consortium, it has delivered more than 30 million life-saving vaccine doses in some of the world’s most…
HPV vaccination will help avert nearly one million cervical cancer deaths and produce an estimated US$ 1.8 billion in economic gains across African implementing countries.
The Vaccine Alliance
The Vaccine Alliance
Gavi draws on the skills of a variety of partners, combining the technical expertise of the development community with the business know-how of the private sector.
Partner countries
Partner countries
Since its inception in 2000, Gavi has helped to immunise a whole generation – over 1.2 billion children – and prevented more than 20.6 million future deaths, helping to halve child mortality in 78 lower‑income countries.
Explore by region:
Africa | Americas | Eastern Mediterranean
Europe | South-East Asia | Western Pacific
Our donors
Our donors
As a public-private partnership, Gavi is funded by governments, foundations, institutions, organisations, corporations and private individuals.

